About the IAS :
IAS the International AIDS Society - leads collective action on every front of the global HIV response through its membership base, scientific authority and convening power.
Founded in 1988, the IAS is the world’s largest association of HIV professionals, with members in more than 170 countries.
Working with its members, the IAS advocates and drives urgent action to reduce the impact of HIV. The IAS is also the steward of the world’s most prestigious HIV conferences : the International AIDS Conference, the IAS Conference on HIV Science, and the HIV Research for Prevention Conference.
The IAS promotes and invests in HIV advocacy and research on key issue areas through our strategic programmes, initiatives, and campaigns that advocate for urgent action to reduce the global impact of HIV, including increased investment in HIV cure research;
optimizing treatment and care for infants, children and adolescents with HIV in resource-limited settings; preventing and treating HIV-related co-infections;
and expanding access to prevention, treatment and care for key populations vulnerable to HIV acquisition such as men who have sex with men, people who inject drugs, sex workers and transgender people including protecting their human rights by combatting punitive laws and discriminatory policies.
More information on IAS can be found at .
Details of Employment :
The Deputy Director (Science), HIV Programmes and Advocacy will be based in Geneva, Switzerland and report to the Director, HIV Programmes and Advocacy.
The position is open-ended and full-time to start as soon as possible.
Purpose of the Position :
The incumbent will lead one of the IAS’s flagship programmes, the Global HIV Vaccine Enterprise ( Enterprise ), providing direction and technical expertise in support of the three pivotal commitments of the Enterprise :
Contribute to the global effort to design innovative HIV prevention efficacy trials in a changing prevention landscape.
Facilitate alignment between stakeholders for the next steps of research and development of immunization for HIV prevention.
Identify issues and roadblocks, old and new, within HIV vaccine research and innovation that the IAS can help resolve or progress as a trusted convener.
The successful candidate will closely monitor the HIV vaccine field and proactively engage with key actors and networks to develop and implement a work plan of convenings, policy development and advocacy actions to unite stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of and future access to an HIV vaccine.
The incumbent will be supported by a small team of project managers and support staff and a pool of senior consultants.
Additionally, as a scientific lead for the IAS, the incumbent will oversee and provide scientific guidance to strengthen other flagship scientific programmes such as the Towards an HIV Cure Initiative and the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER), and serve as the lead science advisor for IAS communications, public affairs, industry and partner engagement, conferences and other events convened by the IAS.
Main Responsibilities :
Line-managing 4-6 direct reports, and matrix managing and mentoring others, the incumbent will be responsible for the following :
Lead, the Global HIV Vaccine Enterprise
Monitor the HIV vaccine field and engage with key research and development consortia leads, including scientific leads represented in the Collaborative HIV Immunogen Project (CHIP), the leads of African and European HIV vaccine research and development initiatives, and the leads of industry HIV vaccine programs.
Engage at conferences and scientific meetings, to proactively identify the most important needs and challenges in HIV vaccine science, trial design, product development, regulatory and access planning
Facilitate information flow among HIV vaccine scientists in different geographies, with an emphasis on elevating opportunities for African scientists to increase awareness of developments in the US and Europe and increase opportunities for collaboration
Lead the Enterprise work plan, including developing clear strategic goals and operational plans for programme execution that reflect inputs from the Enterprise Advisory Group (EAG), the major HIV vaccine funders, including the National Institutes of Health and the Bill and Melinda Gates Foundation, and other stakeholders
Conceptualize and convene stakeholder meetings in-person and virtual of public research institutions, industry, funders and international finance and development agencies to meet work plan objectives across HIV vaccine research, product development, rollout and scale up
Develop and oversee the implementation of a communications and advocacy plan, including development of publications and other collateral, to expand awareness of the latest HIV vaccine science and advocate for enhanced investment in HIV vaccine research and innovation, in collaboration with the IAS Communications and Public Affairs team
Develop and manage annual budgets, and oversee the monitoring, evaluation, and perpetual improvement of the Enterprise
Contribute to concept notes, proposals, outreach and reporting to support resource mobilization efforts for the Enterprise, in collaboration with the IAS Development and